At a glance
- Originator Nonindustrial sources
- Class Antivirals; Small molecules; Stilbenes
- Mechanism of Action RNA-directed DNA polymerase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported HIV infections
Most Recent Events
- 30 Apr 2001 Preclinical development for HIV infections treatment in China (Unknown route)